Takeaways
- Driven by consumer demand, astaxanthin is experiencing huge growth in the European and Asian market, with a 2018 report forecasting that the global market for natural astaxanthin will grow at a CAGR of approximately 13% to reach $770 million by 2024.
- For women with polycystic ovary syndrome undergoing assisted reproductive technology, improvements have been reported in spontaneous ovulations as well as the quality of oocytes and embryos through the use of drugs such as metformin or inositol in different forms, combinations or doses.
- The prenatal supplement market is expected to reach €601 million by 2025, expanding at a CAGR of 8.5% from 2017 to 2025—but the market is flooded with ineffective products, and a key concern for future product development is the stability of main ingredients such as docosahexaenoic acid, iron and folic acid, iodine and vitamin D.
Underwritten by:
Register to access this resource
Registering as a member of Vitafoods Insights will give you free access to premium content including digital magazines, webinars, whitepapers and more.
Download
